EVRY Stock News 1.68 05/13/2014 15:29:15 Everyware Global Inc

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Everyware Global Inc (EVRY) 1.68 $EVRY

EveryWare Global, Inc. Announces Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Mon Mar 31, 3:05PM CDT
EveryWare Global, Inc. ("EveryWare" or the "Company" (Nasdaq:EVRY), announced today financial results for the last three months and full year for 2013. Led by the iconic Oneida and Anchor Hocking brands, EveryWare is the leading global marketer of tabletop and food preparation products for the consumer and foodservice markets.

EveryWare Global Announces Fourth Quarter and Full Year 2013 Earnings Conference Call
GlobeNewswire - Mon Mar 31, 7:31AM CDT
EveryWare Global, Inc., ("EveryWare" or the "Company" (Nasdaq:EVRY) announced today that it will host a conference call to discuss financial results for the fourth quarter and full year ended December 31, 2013 on Tuesday, April 1, 2014 at 10:00 a.m. ET. EveryWare will issue a press release reporting its financial results after the market closes on Monday, March 31, 2014. The Company's Form 10-K will be filed with the SEC on Monday, March 31, 2014.

EveryWare Global (EVRY) Soars: Stock Rises 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 8:39AM CDT
EveryWare Global, Inc. was a big mover last session, as its shares rose above 9% on the day.

EveryWare Global Announces Postponement of Fourth Quarter and Full Year 2013 Earnings Release and Conference Call
GlobeNewswire - Wed Mar 05, 4:15PM CST
EveryWare Global, Inc. (Nasdaq:EVRY) announced today that it is postponing its fourth quarter and full year 2013 earnings release and investor conference call originally scheduled for Thursday, March 6, 2014.

EveryWare Global Announces Leadership Transition
GlobeNewswire - Tue Feb 25, 9:25AM CST
Branded Consumer Products Veteran Sam Solomon Appointed Interim CEO

Deal Or No Deal: 8 Undervalued Small Cap Stocks
at The Street - Tue Feb 18, 4:37PM CST
James Dennin, Kapitall: We screened for undervalued small cap stocks by looking at price of sales and return on equity. [...]

EveryWare Global to Host Fourth Quarter and Full Year 2013 Earnings Conference Call
GlobeNewswire - Wed Feb 12, 8:46AM CST
EveryWare Global, Inc., ("EveryWare" or the "Company" (Nasdaq:EVRY) announced today that it will host a conference call to discuss financial results for the fourth quarter and full year ended December 31, 2013 on Thursday, March 6, 2014 at 10:00 a.m. ET. EveryWare will issue a press release reporting its results before the market opens that morning.

Ball Corporation Rises on New Repurchase Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 12:10PM CST
Ball Corporation's Board has sanctioned a share repurchase program.

EveryWare Global, Inc. Announces Update on Corporate Integration
GlobeNewswire - Mon Jan 27, 2:30PM CST
EveryWare Global, Inc. ("EveryWare" (Nasdaq:EVRY), a global leader in the consumer tabletop and foodservice markets, announced today that it plans to close its regional office in Oneida, N.Y., as part of its ongoing integration of the Oneida business. A smaller satellite office in Melville, New York, also will be closed.

EveryWare Global to Present at Upcoming January Investor Conferences
Business Wire - Tue Jan 07, 11:43AM CST
EveryWare Global, Inc. (Nasdaq: EVRY) announced today that it will present to attendees of the CJS Securities 14th Annual New Ideas For The New Year Conference on January 15, 2014. Chief Executive Officer, John Sheppard is scheduled to present at the conference. Chief Financial Officer, Bernard Peters will also attend the event and participate in one-on-one meetings. This event will not be webcast.

Ball Corp. Builds Structure for JPSS-1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 05, 5:09AM CST
Ball Corp.'s unit Ball Aerospace has completed the primary bus structure for JPSS-1.

Oneida Ltd. and Anchor Hocking Launch New Consumer Website with Innovative Responsive Design
PRWeb - Wed Nov 27, 3:01PM CST
EveryWare Global, Inc. creates a new brand experience for customers with a new consumer website. Two great legacy brands, Oneida an exceptional quality flatware company since 1880 and Anchor Hocking a proud American glassware manufacturer since 1905, are now fully integrated online. The new consumer website was released earlier this month with increased functionality designed to create a seamless experience for customers, no matter what device they are using.

EveryWare Global, Inc. [EVRY] to Ring The NASDAQ Stock Market Closing Bell
GlobeNewswire - Fri Nov 22, 9:00AM CST
What:

Moody's Assigns Baa1 Rating to Crown Units - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 21, 11:30AM CST
Moody's assigned Baa1 rating for Crown's new senior secured credit facilities and term loans.

Oneida LTD. and Anchor Hocking Announce Dishing Up Thanks Facebook Sweepstakes
PRWeb - Wed Nov 20, 3:25AM CST
Oneida Ltd. and Anchor Hocking are kicking off the season with an exciting Dishing Up Thanks social media sweepstakes. The sweepstakes is being hosted on both Oneida and Anchor consumer Facebook pages from November 15 - December 15, 2013. A winner will be selected from each page, so participants can double their chances to win by signing up on both pages. The prize for this year's sweepstakes includes a service for twelve in dinnerware, flatware and glassware, plus a year supply of Cascade Platinum.

Ball Corp. to Shut Danville Unit, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 18, 2:20PM CST
Ball Corp. to close Danville aerosol packaging manufacturing plant.

EveryWare Global, Inc. to Present at Upcoming Investor Conferences
GlobeNewswire - Wed Sep 18, 9:08AM CDT
EveryWare Global, Inc. (Nasdaq:EVRY) announced today that Chief Executive Officer, John Sheppard is scheduled to present at the Imperial Capital Global Opportunities Conference being held at the Waldorf Astoria in New York, NY on September 19, 2013 at 9:00 am ET.

EveryWare Global, Inc. Announces Pricing of Secondary Offering of 1,750,000 Shares of Common Stock by Selling Stockholders
GlobeNewswire - Fri Sep 13, 3:05PM CDT
EveryWare Global, Inc. (Nasdaq:EVRY), announced that certain of its stockholders have priced a secondary offering of 1,750,000 shares of its common stock at a price to the public of $11.50 per share. The selling stockholders have granted the underwriters an option to purchase up to an additional 262,500 shares of common stock from the selling stockholders at the secondary offering price to cover over-allotments, if any.

EveryWare Global, Inc. Announces Secondary Offering of 4,000,000 Shares of Common Stock by Selling Stockholders
GlobeNewswire - Thu Sep 12, 3:24PM CDT
EveryWare Global, Inc. (Nasdaq:EVRY), announced a secondary offering of 4,000,000 shares of its common stock by investment funds managed by Monomoy Capital Partners and certain other stockholders who are party to a registration rights agreement, including certain members of management. The offering is being made pursuant to a shelf registration statement filed with the Securities and Exchange Commission. The selling stockholders expect to grant the underwriters an option to purchase up to an additional 600,000 shares of common stock from the selling stockholders to cover over-allotments, if any.

OTC Daily Alert Stock Watch - EveryWare Global, Inc. (NASDAQ: EVRY)
WorldStockWire - Sat Aug 17, 5:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading